Bayer Loses Nexavar Rights In India Natco Pharma Granted License
The Patent Office granted India in a historic ruling, the first compulsory license for manufacturer of generic NATCO Pharma Bayer AG Nexavar cancer treatment, which looks expensive price the price of the medicinal product a whopping 97% reductions in the country.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment